Vortrag am FONDS professionell KONGRESSJPMorgan Funds - Thematics - Genetic Therapies A (acc) - EUR (hedged)
| MVD-Fonds Rating | EDA |
|---|---|
  | 75 |
ISIN: LU2053353079 | WKN: A2PR3U
KAG: JPMorgan AM (EU)
NAV: 82,01 EUR am 10.07.2025
Portfolio
Watchlist
KursalarmChart
Kennzahlen JPMorgan Funds - Thematics - Genetic Therapies A (acc) - EUR (hedged)
| 1M | 6M | 1J | 3J | 5J | 10J | Beginn | |
| Performance | +2,22% | -4,57% | -13,60% | -27,28% | -42,61% | - | -17,99% |
| Volatilität | +14,18% | +26,87% | +24,18% | +22,64% | +25,38% | - | +26,09% |
| Sharpe Ratio | +2,02 | -0,41 | -0,64 | -0,53 | -0,49 | - | -0,21 |
| Bester Monat | - | +4,81% | +8,41% | +10,38% | +15,71% | - | +18,10% |
| Schl. Monat | - | -5,89% | -7,48% | -11,60% | -17,61% | - | -17,61% |
| Max. Verlust | -4,76% | -24,36% | -34,35% | -45,24% | -64,74% | - | -64,74% |
Monatsperformance JPMorgan Funds - Thematics - Genetic Therapies A (acc) - EUR (hedged)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
| Januar | +2,97% | -0,60% | +4,85% | -17,61% | +6,61% |
| Februar | -3,96% | +8,87% | -6,11% | -2,80% | -7,09% |
| März | -5,89% | -2,68% | -3,42% | +2,93% | -4,63% |
| April | -2,91% | -10,72% | +1,08% | -10,23% | +2,86% |
| Mai | -3,60% | +1,33% | +0,92% | -7,55% | -3,17% |
| Juni | +4,49% | +1,80% | -0,29% | +2,83% | +9,46% |
| Juli | +4,81% | +8,41% | +0,61% | +9,15% | -4,75% |
| August | - | -2,06% | -3,25% | +0,02% | +4,81% |
| September | - | -4,12% | -5,50% | -5,38% | -5,98% |
| Oktober | - | -2,83% | -11,60% | +1,31% | -3,95% |
| November | - | +0,15% | +10,38% | +0,32% | -5,26% |
| Dezember | - | -7,48% | +8,96% | -5,32% | -0,23% |
| Gesamt | -4,60% | -11,10% | -5,42% | -30,08% | -12,24% |
Diese Fonds könnten Sie auch interessieren
Vergleichen Sie diese Fonds mit Ihrem ausgewähltem Fonds (JPMorgan Funds - Thematics - Genetic Therapies) oder suchen Sie weitere Top-Fonds zum Thema Aktien (Branche Gesundheit/Pharma) weltweit in EUR:
Fonds vergleichenWeitere ähnliche Fonds